Oxford Begins Bundibugyo Ebola Vaccine Trial as Outbreaks Hit Congo and Uganda
The University of Oxford has vaccinated the first participant in a phase 1 trial of a Bundibugyo Ebola vaccine, 68 days after the World Health Organization declared an international public-health emergency.
